Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.9 EUR | -0.48% | -3.26% | -32.68% |
05-31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
05-31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.68% | 1.79B | |
+55.55% | 59.28B | |
+42.78% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- Galapagos Appoints Former Johnson & Johnson Exec to Succeed Retiring CEO